Keiko Yamauchi Selected Research

Cytokines

1/2009

Gly80Ser polymorphism of phospholipase A2-IID is associated with cytokine inducibility in A549 cells.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Keiko Yamauchi Research Topics

Disease

9	Chronic Obstructive Pulmonary Disease (COPD) 01/2022 - 01/2009
5	Pneumonia (Pneumonitis) 01/2020 - 01/2011
4	Lung Neoplasms (Lung Cancer) 07/2021 - 01/2014
3	Emphysema 01/2021 - 01/2014
2	Pulmonary Emphysema 01/2022 - 01/2014
2	Adenocarcinoma of Lung 07/2021 - 01/2019
2	Respiratory Tract Diseases (Respiratory Tract Disease) 11/2019 - 01/2019
2	Neoplasms (Cancer) 01/2014 - 11/2006
1	Hemorrhage 01/2022
1	Inflammation (Inflammations) 01/2021
1	Pulmonary Tuberculosis 01/2021
1	Tuberculosis (Tuberculoses) 01/2021
1	Iron Deficiencies 01/2020
1	Pain (Aches) 05/2019
1	Dehydration (Water Stress) 03/2019
1	Respiratory Tract Infections (Respiratory Tract Infection) 01/2019
1	Interstitial Lung Diseases (Interstitial Lung Disease) 01/2019
1	Respiratory Insufficiency (Respiratory Failure) 03/2018
1	Heart Failure 03/2018
1	Connective Tissue Diseases (Connective Tissue Disease) 01/2013
1	Lung Diseases (Lung Disease) 04/2012
1	Acute Lung Injury 01/2011
1	Hypoxia (Hypoxemia) 01/2011
1	Left Ventricular Hypertrophy (Ventricular Hypertrophy, Left) 01/2011
1	Body Weight (Weight, Body) 01/2009
1	Melanoma (Melanoma, Malignant) 11/2006
1	Cough 09/2005
1	Ulcerative Colitis 09/2005
1	Fever (Fevers) 09/2005
1	Dyspnea (Shortness of Breath) 09/2005
1	Pleurisy (Pleuritis) 09/2005
1	Pleural Effusion (Pleural Effusions) 09/2005
1	Vasculitis (Vasculitides) 12/2003
1	Hyperthyroidism 12/2003
1	Glomerulonephritis 12/2003

Drug/Important Bio-Agent (IBA)

4	Biomarkers (Surrogate Marker)IBA 07/2021 - 01/2011
3	SmokeIBA 01/2022 - 01/2013
2	Pancreatic Elastase (Elastase)IBA 01/2022 - 01/2014
2	CC ChemokinesIBA 01/2022 - 01/2016
2	Chemokine CCL17IBA 01/2022 - 01/2021
2	Anti-Bacterial Agents (Antibiotics)IBA 03/2019 - 09/2005
2	Oxygen (Dioxygen)IBA 01/2019 - 03/2018
2	SelectinsIBA 01/2019 - 01/2011
1	LigandsIBA 01/2022
1	Hemostatics (Antihemorrhagics)IBA 01/2022
1	Carboplatin (JM8)FDA LinkGeneric 07/2021
1	Paclitaxel (Taxol)FDA LinkGeneric 07/2021
1	Pemetrexed (MTA)FDA Link 07/2021
1	Bevacizumab (Avastin)FDA Link 07/2021
1	AcidsIBA 01/2021
1	GoldIBA 01/2021
1	Air Pollutants (Pollutants, Air)IBA 11/2019
1	Carbon MonoxideIBA 05/2019
1	ErbB Receptors (EGF Receptor)IBA 01/2019
1	E-SelectinIBA 01/2019
1	osimertinibIBA 01/2019
1	Fatty Acid-Binding ProteinsIBA 03/2018
1	Proteins (Proteins, Gene)FDA Link 03/2018
1	Fatty Acid Binding Protein 3IBA 03/2018
1	PotassiumIBA 03/2018
1	Urethane (Ethyl Carbamate)IBA 01/2017
1	LipopolysaccharidesIBA 01/2016
1	Chemokine CCL1IBA 01/2016
1	AdiponectinIBA 01/2014
1	Hyaluronic Acid (Hyaluronan)IBA 01/2014
1	EnzymesIBA 01/2014
1	ImmunosorbentsIBA 01/2014
1	Matrix Metalloproteinases (MMPs)IBA 01/2014
1	Serum AlbuminIBA 01/2014
1	AntibodiesIBA 01/2013
1	AutoantigensIBA 01/2013
1	MafB Transcription FactorIBA 01/2013
1	Surface-Active Agents (Surfactants)IBA 04/2012
1	LipidsIBA 04/2012
1	Adenosine Triphosphate (ATP)IBA 01/2011
1	Brain Natriuretic Peptide (Natrecor)FDA Link 01/2011
1	Uric Acid (Urate)IBA 01/2011
1	CytokinesIBA 01/2009
1	Phospholipases (Phospholipase)IBA 01/2009
1	Biological ProductsIBA 11/2006
1	Mesalamine (Mesalazine)FDA LinkGeneric 09/2005
1	Adrenal Cortex Hormones (Corticosteroids)IBA 09/2005
1	Propylthiouracil FDA Link 12/2003
1	Antineutrophil Cytoplasmic Antibodies (ANCA)IBA 12/2003

Therapy/Procedure

2	Therapeutics 03/2018 - 12/2003
1	Intranasal Administration 01/2022
1	Hysterectomy 01/2022
1	Drug Therapy (Chemotherapy) 07/2021
1	Activities of Daily Living (ADL) 03/2019
1	Bioreactors (Bioreactor) 11/2006